Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBunzl Regulatory News (BNZL)

Share Price Information for Bunzl (BNZL)

Share Price is delayed by 15 minutes
Get Live Data
2,474.00    0.00 (0.00%)
Bid:
2,000.00
Ask:
2,782.00
Spread: 782.00 (39.10%)
Market Cap: £7.94b
BNZL Live PriceLast checked at - London Stock Exchange

Intraday Bunzl Share Chart

2025 Share Buyback Programme - Update

3 Mar 2025 07:01

RNS Number : 9768Y
Bunzl PLC
03 March 2025
 

3 March 2025

 

2025 Share Buyback Programme - Update

 

As announced in its pre-close statement dated 17 December 2024, Bunzl plc ("Bunzl" or the "Company") is executing a £200m share buyback during 2025 (the "2025 Programme"). 

The Company today announces that it has completed the first £50m tranche of the 2025 Programme, launched on 2 January 2025, and has entered into an agreement to repurchase further shares of up to £150m, to be completed no later than 31 December 2025.

A maximum number of 25,093,195 ordinary shares may be repurchased under the agreement, representing the remaining authority granted by shareholders at Bunzl's annual general meeting ("AGM") on 24 April 2024. Any purchases to be made under the 2025 Programme after the expiry of this authority will be made subject to the authority to be requested from shareholders at Bunzl's 2025 AGM. The purpose of the 2025 Programme is to reduce the issued share capital of the Company.

UBS AG London Branch ("UBS") has been instructed by Bunzl to manage this phase of the 2025 Programme. UBS will carry out the instruction through the acquisition of ordinary shares in Bunzl, acting as riskless principal, for subsequent repurchase by Bunzl. Any purchase of ordinary shares made by UBS in relation to the 2025 Programme will be carried out on the London Stock Exchange or another recognised investment exchange.

This arrangement is in accordance with Chapter 9 of the UK Listing Rules and Bunzl's general authority to repurchase ordinary shares. The share buyback programme will be conducted within the parameters prescribed by the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 (both as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018 and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019) and with regard to regulatory technical standards for the conditions applicable to buy-back programmes and stabilisation measures. Bunzl will announce any market repurchase of ordinary shares no later than 7.30 a.m. on the business day following the calendar day on which the repurchase occurred. Ordinary shares purchased under the share buyback programme will be cancelled.

UBS may undertake transactions in Bunzl's ordinary shares in order to manage its market exposure under the share buyback programme. UBS will make any disclosures it is legally required to make in relation to such transactions.

 

Enquiries:

Bunzl plc

 

Frank van Zanten, Chief Executive Officer

 

Richard Howes, Chief Financial Officer

 

Sunita Entwisle, Head of Investor Relations

 

Tel: +44 (0)20 7725 5000

Teneo

 

Martin Robinson

 

Olivia Peters

 

Tel: +44 (0)20 7353 4200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBIGDDDUDDGUI
Date   Source Headline
27th Feb 20177:00 amRNSAcquisition
27th Feb 20177:00 amRNSFinal Results
3rd Feb 20175:37 pmRNSDirector/PDMR Shareholding
1st Feb 20173:27 pmRNSTotal Voting Rights
18th Jan 20175:02 pmRNSDirector/PDMR Shareholding
10th Jan 20177:00 amRNSAcquisition
6th Jan 201712:00 pmRNSDirector/PDMR Shareholding
3rd Jan 201710:43 amRNSTotal Voting Rights
28th Dec 20162:00 pmRNSHolding(s) in Company
19th Dec 20162:55 pmRNSHolding(s) in Company
15th Dec 20167:00 amRNSTrading Statement
12th Dec 20164:22 pmRNSHolding(s) in Company
9th Dec 20164:15 pmRNSHolding(s) in Company
1st Dec 20169:00 amRNSTotal Voting Rights
23rd Nov 20165:16 pmRNSDirector/PDMR Shareholding
22nd Nov 20167:00 amRNSAcquisition
1st Nov 20164:58 pmRNSBlock listing Interim Review
1st Nov 20164:49 pmRNSTotal Voting Rights
26th Oct 20167:00 amRNSTrading Statement
11th Oct 20165:15 pmRNSDirector/PDMR Shareholding
11th Oct 20164:38 pmRNSDirector/PDMR Shareholding
7th Oct 20164:44 pmRNSDirector/PDMR Shareholding
3rd Oct 201611:37 amRNSTotal Voting Rights
26th Sep 20163:45 pmRNSDirector/PDMR Shareholding
21st Sep 20164:12 pmRNSDirector/PDMR Shareholding
14th Sep 20165:07 pmRNSDirector/PDMR Shareholding
13th Sep 201610:38 amRNSDirectorate Change
5th Sep 20163:13 pmRNSHolding(s) in Company
2nd Sep 20163:13 pmRNSDirector/PDMR Shareholding
1st Sep 201611:11 amRNSTotal Voting Rights
30th Aug 20164:55 pmRNSDirector/PDMR Shareholding
30th Aug 20169:30 amRNSDividend Declaration
30th Aug 20167:00 amRNSHalf-year Report
30th Aug 20167:00 amRNSAcquisition
1st Aug 20169:31 amRNSTotal Voting Rights
29th Jul 201610:08 amRNSDirectorate Change
15th Jul 20164:32 pmRNSDirector/PDMR Shareholding
5th Jul 20161:20 pmRNSDirector/PDMR Shareholding
4th Jul 201610:37 amRNSHolding(s) in Company
1st Jul 20161:13 pmRNSTotal Voting Rights
1st Jul 201612:16 pmRNSHolding(s) in Company
30th Jun 20163:48 pmRNSDirector/PDMR Shareholding
29th Jun 20164:36 pmRNSDirector/PDMR Shareholding
29th Jun 201610:12 amRNSHolding(s) in Company
29th Jun 20167:00 amRNSTrading Statement
27th Jun 20169:42 amRNSHolding(s) in Company
1st Jun 20162:00 pmRNSTotal Voting Rights
23rd May 20164:54 pmRNSDirector/PDMR Shareholding
11th May 20161:54 pmRNSAdditional Listing
5th May 20167:00 amRNSAcquisition

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.